PDF herunterladen
Semin Thromb Hemost 2024; 50(01): 104-114
DOI: 10.1055/s-0043-1772456
Review Article

In Search of the Holy Grail of Artificial Hearts: Are We There Yet?

Oksana Volod
1   Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, California
,
Modesto J. Colon
2   Department of Surgery, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona
,
Francisco A. Arabía
3   Advanced Heart Program, Department of Surgery and Medicine, Banner Health-University of Arizona College of Medicine, Phoenix, Arizona
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints

Abstract

The total artificial heart (TAH) has a long and rich history, being the product of decades of innovation, hard work, and dedication. This review examines the history of the TAH, a device that has revolutionized the treatment of end-stage biventricular heart failure. It reviews the development of the device from early concepts to the current state-of-the-art device, the SynCardia TAH, which has been implanted in over 2,000 patients worldwide. The article also discusses the challenges and successes experienced by researchers, clinicians, and patients throughout the development of TAH devices. Our focus will also be on discussing the hemostatic alterations in patients implanted with TAH and anticoagulation strategies to decrease associated thromboembolic risks. The article concludes with a look at other novel TAH devices and the future of TAH as an increasingly viable treatment for end-stage heart failure.

Keywords

total artificial heart - history - anticoagulation


Publikationsverlauf

Artikel online veröffentlicht:
21. August 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. [published correction appears in Cardiovasc Res. 2023 Feb 09:] Cardiovasc Res 2023; 118 (17) 3272-3287
    CrossrefPubMedGoogle Scholar
  • 2 Seferović PM, Vardas P, Jankowska EA. et al; National Heart Failure Societies of the ESC member countries (see Appendix). The Heart Failure Association Atlas: heart failure epidemiology and management statistics 2019. Eur J Heart Fail 2021; 23 (06) 906-914
    CrossrefPubMedGoogle Scholar
  • 3 Heidenreich PA, Albert NM, Allen LA. et al; American Heart Association Advocacy Coordinating Committee, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Radiology and Intervention, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Stroke Council. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 2013; 6 (03) 606-619
    CrossrefPubMedGoogle Scholar
  • 4 Benjamin EJ, Muntner P, Alonso A. et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. [published correction appears in Circulation. 2020 Jan 14;141(2):e33] Circulation 2019; 139 (10) e56-e528
    CrossrefPubMedGoogle Scholar
  • 5 Elflein J. Rate of Heart Transplants Worldwide Between 2011 and 2021. Statista. Zugriff am 01. Juni 2023 unter: https://www.statista.com/statistics/1083471/rate-of-heart-transplant-activities-worldwide/
    PubMedGoogle Scholar
  • 6 Organ Donation Statistics. organdonor.gov. Zugriff am 01. Juni 2023 unter: https://www.organdonor.gov/learn/organ-donation-statistics
    PubMedGoogle Scholar
  • 7 Rothblatt M. Commentary on achievement of first life-saving xenoheart transplant. Xenotransplantation 2022; 29 (03) e12746
    CrossrefPubMedGoogle Scholar
  • 8 Griffith BP, Goerlich CE, Singh AK. et al. Genetically modified porcine-to-human cardiac xenotransplantation. N Engl J Med 2022; 387 (01) 35-44
    CrossrefPubMedGoogle Scholar
  • 9 Chaban R, Cooper DKC, Pierson III RN. Pig heart and lung xenotransplantation: present status. J Heart Lung Transplant 2022; 41 (08) 1014-1022
    CrossrefPubMedGoogle Scholar
  • 10 Mohiuddin MM, Goerlich CE, Singh AK. et al. Progressive genetic modifications of porcine cardiac xenografts extend survival to 9 months. Xenotransplantation 2022; 29 (03) e12744
    CrossrefPubMedGoogle Scholar
  • 11 Mehra MR, Uriel N, Naka Y. et al; MOMENTUM 3 Investigators. A fully magnetically levitated left ventricular assist device—final report. N Engl J Med 2019; 380 (17) 1618-1627
    CrossrefPubMedGoogle Scholar
  • 12 Arabía FA, Cantor RS, Koehl DA. et al. Interagency registry for mechanically assisted circulatory support report on the total artificial heart. J Heart Lung Transplant 2018; 37 (11) 1304-1312
    CrossrefPubMedGoogle Scholar
  • 13 Glass heart. 1935; 1 (Jul): 41-42
    PubMedGoogle Scholar
  • 14 Bing R. John H. Gibbon, Jr. Cardiopulmonary bypass–triumph of perserverance and character. Clin Cardiol 1994; 17 (08) 456-457
    CrossrefPubMedGoogle Scholar
  • 15 Hill JD. John H. Gibbon, Jr. Part I. The development of the first successful heart-lung machine. Ann Thorac Surg 1982; 34 (03) 337-341
    CrossrefPubMedGoogle Scholar
  • 16 Matskeplishvili S. Vladimir Petrovich Demikhov (1916-1998): a pioneer of transplantation ahead of his time, who lived out the end of his life as an unknown and in poor circumstances. Eur Heart J 2017; 38 (46) 3406-3410
    PubMedGoogle Scholar
  • 17 Gaitan BD, Thunberg CA, Stansbury LG. et al. Development, current status, and anesthetic management of the implanted artificial heart. J Cardiothorac Vasc Anesth 2011; 25 (06) 1179-1192
    CrossrefPubMedGoogle Scholar
  • 18 Lavietes S. William Glenn, 88, surgeon who invented heart procedure. The New York Times. Accessed June, 1, 2023 at: https://www.nytimes.com/2003/03/17/us/william-glenn-88-surgeon-who-invented-heart-procedure.html
    PubMedGoogle Scholar
  • 19 Medgadget. Paul Winchell and the artificial heart. Zugriff am 01. Juni 2023 unter: https://www.medgadget.com/2005/07/paul_winchell_a.html
    PubMedGoogle Scholar
  • 20 Cooley DA. In Memorium: Willem Johan Kolff 1911–2009. Tex Heart Inst J 2009; 36: 83-84
    PubMedGoogle Scholar
  • 21 Nosé Y. The birth of the artificial heart programs in the world: a special tribute to Tetsuo Akutsu and Valerÿ Shumakov. Artif Organs 2008; 32 (09) 667-683
    CrossrefPubMedGoogle Scholar
  • 22 Ticker SM. The Quest to Create an Artificial Heart. New York: Broadway Books; 2019
    Google Scholar
  • 23 Cooper DKC. Christiaan Barnard-the surgeon who dared: the story of the first human-to-human heart transplant. Glob Cardiol Sci Pract 2018; 2018 (02) 11
    PubMedGoogle Scholar
  • 24 Cooley DA. The total artificial heart as a bridge to cardiac transplantation: personal recollections. Tex Heart Inst J 2001; 28 (03) 200-202
    PubMedGoogle Scholar
  • 25 DeVries WC, Anderson JL, Joyce LD. et al. Clinical use of the total artificial heart. N Engl J Med 1984; 310 (05) 273-278
    CrossrefPubMedGoogle Scholar
  • 26 Olsen DB, Unger F, Oster H. et al. Thrombus generation within the artificial heart. J Thorac Cardiovasc Surg 1975; 70 (02) 248-255
    CrossrefPubMedGoogle Scholar
  • 27 Kessler TR, Pons AB, Jarvik RK, Lawson JH, Razzeca KJ, Kolff WJ. Elimination of predilection sites for thrombus formation in the total artificial heart–before and after. Trans Am Soc Artif Intern Organs 1978; 24: 532-536
    PubMedGoogle Scholar
  • 28 Zdrahala RJ, Zdrahala IJ. Biomedical applications of polyurethanes: a review of past promises, present realities, and a vibrant future. J Biomater Appl 1999; 14 (01) 67-90
    CrossrefPubMedGoogle Scholar
  • 29 Walenga JM, Hoppensteadt D, Fareed J, Pifarré R. Hemostatic abnormalities in total artificial heart patients as detected by specific blood markers. Ann Thorac Surg 1992; 53 (05) 844-850
    CrossrefPubMedGoogle Scholar
  • 30 Torregrossa G, Morshuis M, Varghese R. et al. Results with SynCardia total artificial heart beyond 1 year. ASAIO J 2014; 60 (06) 626-634
    CrossrefPubMedGoogle Scholar
  • 31 Reich HJ, Morgan J, Arabia F. et al. Comparative analysis of von Willebrand factor profiles after implantation of left ventricular assist device and total artificial heart. J Thromb Haemost 2017; 15 (08) 1620-1624
    CrossrefPubMedGoogle Scholar
  • 32 Haglund N, Peter K. Medscape: Medscape access [Internet]. Emedicine.medscape.com. 2014 [5 July 2014]. Zugriff am 01. Juni 2023 unter: http://emedicine.medscape.com/article/2052514-overview
    PubMedGoogle Scholar
  • 33 Grubin D. The mysterious human heart. The replacement heart. Jarvik-7 | PBS [Internet]. Pbs.org. 2007 [5 July 2014]. Zugriff am 01. Juni 2023 unter: http://www.pbs.org/wnet/heart/episode1/replacement.htm
    PubMedGoogle Scholar
  • 34 Ford O. Medical device daily | Today's headlines [Internet]. Medicaldevicedaily.com. 2010 [5 July 2014]. Zugriff am 01. Juni 2023 unter: http://www.medicaldevicedaily.com/servlet/com.accumedia.web.Dispatcher
    PubMedGoogle Scholar
  • 35 Jaroszewski DE, Anderson EM, Pierce CN, Arabia FA. The SynCardia freedom driver: a portable driver for discharge home with the total artificial heart. J Heart Lung Transplant 2011; 30 (07) 844-845
    CrossrefPubMedGoogle Scholar
  • 36 SynCardia Systems, Inc.. Zugriff am 01. Juni 2023 unter: http://www.syncardia.com
    PubMed
  • 37 Coyan GN, Huckaby LV, Diaz-Castrillon CE, Miguelino AM, Kilic A. Trends and outcomes following total artificial heart as bridge to transplant from the UNOS database. J Card Surg 2022; 37 (05) 1215-1221
    CrossrefPubMedGoogle Scholar
  • 38 Netuka I, Pya Y, Poitier B. et al. First clinical experience with the pressure sensor-based autoregulation of blood flow in an artificial heart. ASAIO J 2021; 67 (10) 1100-1108
    CrossrefPubMedGoogle Scholar
  • 39 Schroder JN, McCartney SL, Jansen P. et al. The first autoregulated total artificial heart implant in the United States. Ann Thorac Surg Short Rep 2023; 1 (01) 185-187
    CrossrefPubMedGoogle Scholar
  • 40 CARMAT SA. Zugriff am 01. Juni 2023 unter: https://www.carmatsa.com/
    PubMed
  • 41 Emmanuel S, Jansz P, McGiffin D. et al. Anatomical human fitting of the BiVACOR total artificial heart. Artif Organs 2022; 46 (01) 50-56
    CrossrefPubMedGoogle Scholar
  • 42 BiVACOR Inc. https://www.bivacor.com/
    PubMed
  • 43 Dal Sasso E, Bagno A, Scuri STG, Gerosa G, Iop L. The biocompatibility challenges in the total artificial heart evolution. Annu Rev Biomed Eng 2019; 21: 85-110
    CrossrefPubMedGoogle Scholar
  • 44 Vasin SL, Rosanova IB, Sevastianov VI. The role of proteins in the nucleation and formation of calcium-containing deposits on biomaterial surfaces. J Biomed Mater Res 1998; 39 (03) 491-497
    CrossrefPubMedGoogle Scholar
  • 45 Shumakov VI, Rosanova IB, Vasin SL, Salomatina LA, Sevastianov VI. Biomaterial calcification without direct material-cell interaction. ASAIO Trans 1990; 36 (03) M181-M184
    PubMedGoogle Scholar
  • 46 Vasků J, Urbánek P. Electron microscopic study of driving diaphragms in long-term survival with a total artificial heart. Artif Organs 1995; 19 (04) 344-354
    CrossrefPubMedGoogle Scholar
  • 47 Smadja DM, Susen S, Rauch A. et al. The Carmat bioprosthetic total artificial heart is associated with early hemostatic recovery and no acquired von Willebrand syndrome in calves. J Cardiothorac Vasc Anesth 2017; 31 (05) 1595-1602
    CrossrefPubMedGoogle Scholar
  • 48 Szefner J. Control and treatment of hemostasis in cardiovascular surgery. The experience of La Pitié Hospital with patients on total artificial heart. Int J Artif Organs 1995; 18 (10) 633-648
    CrossrefPubMedGoogle Scholar
  • 49 Leprince P, Bonnet N, Rama A. et al. Bridge to transplantation with the Jarvik-7 (CardioWest) total artificial heart: a single-center 15-year experience. J Heart Lung Transplant 2003; 22 (12) 1296-1303
    CrossrefPubMedGoogle Scholar
  • 50 Kirsch MEW, Nguyen A, Mastroianni C. et al. SynCardia temporary total artificial heart as bridge to transplantation: current results at la pitié hospital. Ann Thorac Surg 2013; 95 (05) 1640-1646
    CrossrefPubMedGoogle Scholar
  • 51 Copeland J, Copeland H, Nolan P, Gustafson M, Slepian M, Smith R. Results with an anticoagulation protocol in 99 SynCardia total artificial heart recipients. ASAIO J 2013; 59 (03) 216-220
    CrossrefPubMedGoogle Scholar
  • 52 Volod O, Lam LD, Lin G. et al. Role of thromboelastography platelet mapping and international normalized ratio in defining “normocoagulability” during anticoagulation for mechanical circulatory support devices: a pilot retrospective study. ASAIO J 2017; 63 (01) 24-31
    CrossrefPubMedGoogle Scholar
  • 53 Volod O, Arabia FA, Lam LD, Runge A, Cheng C, Czer LSC. Platelet mapping by thromboelastography and whole blood aggregometry in adult patients supported by mechanical circulatory support device on aspirin therapy. J Extra Corpor Technol 2020; 52 (01) 13-21
    CrossrefPubMedGoogle Scholar
  • 54 Malas J, Chen Q, Akhmerov A. et al. Experience with SynCardia total artificial heart as a bridge to transplantation in 100 patients. Ann Thorac Surg 2023; 115 (03) 725-732
    CrossrefPubMedGoogle Scholar
  • 55 Volod O, Lam LD, Mirocha J, Czer LS, Moriguchi JD, Arabia FA. TEG Platelet Mapping (TEG PM) guided management of patients with total artificial heart (TAH): a single -center 5 - year experience. Paper presented at: ISMCS 25th International Congress, Tucson, Arizona, October 2017
    PubMedGoogle Scholar
  • 56 Ramirez A, Riley JB, Joyce LD. Multi-targeted antithrombotic therapy for total artificial heart device patients. J Extra Corpor Technol 2016; 48 (01) 27-34
    CrossrefPubMedGoogle Scholar
  • 57 Feldman D, Pamboukian SV, Teuteberg JJ. et al; International Society for Heart and Lung Transplantation. The 2013 International Society for Heart and Lung transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant 2013; 32 (02) 157-187
    CrossrefPubMedGoogle Scholar
  • 58 Potapov EV, Antonides C, Crespo-Leiro MG. et al. 2019 EACTS expert consensus on long-term mechanical circulatory support. Eur J Cardiothorac Surg 2019; 56 (02) 230-270
    CrossrefPubMedGoogle Scholar
  • 59 Latrémouille C, Carpentier A, Leprince P. et al. A bioprosthetic total artificial heart for end-stage heart failure: Results from a pilot study. J Heart Lung Transplant 2018; 37 (01) 33-37
    CrossrefPubMedGoogle Scholar
  • 60 Smadja DM, Ivak P, Pya Y. et al. Intermediate-dose prophylactic anticoagulation with low molecular weight heparin is safe after bioprosthetic artificial heart implantation. J Heart Lung Transplant 2022; 41 (09) 1214-1217
    CrossrefPubMedGoogle Scholar
  • 61 Glynn J, Song H, Hull B. et al. The OregonHeart total artificial heart: design and performance on a mock circulatory loop. Artif Organs 2017; 41 (10) 904-910
    CrossrefPubMedGoogle Scholar
  • 62 Fumoto H, Horvath DJ, Rao S. et al. In vivo acute performance of the Cleveland Clinic self-regulating, continuous-flow total artificial heart. J Heart Lung Transplant 2010; 29 (01) 21-26
    CrossrefPubMedGoogle Scholar
  • 63 Fresiello L, Najar A, Brynedal Ignell N. et al. Hemodynamic characterization of the Realheart® total artificial heart with a hybrid cardiovascular simulator. Artif Organs 2022; 46 (08) 1585-1596
    CrossrefPubMedGoogle Scholar
  • 64 Atsumi K. How the dream of an “artificial heart” was realized in Japan. Artif Organs 2012; 36 (05) 453-459
    CrossrefPubMedGoogle Scholar
  • 65 Stoddard W, Hirschhorn M, Thompson Johnson A. et al. BIO27: advancements of DragonHeart BiVentricular assist device. ASAIO J 2022; 68 (Suppl. 02) 24
    CrossrefPubMedGoogle Scholar